BriaCell Therapeutics Corp. (BCTX) shareholders
Close on Nov 13, 2026Market cap $29.60MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Marc Lustig Joint filing with L5 Capital Inc. (10.40%) | 4,031,370 | 10.70% | 13D (active) amendment | Dec 10, 2024 |
| Richard Abbe | 1,600,000 | 9.10% | 13G (passive) | Jul 15, 2025 |
| Copia Fund (Cayman) LP | 818,375 | 5.10% | 13G (passive) | Dec 29, 2023 |
| Kenneth Griffin Joint filing with Citadel Advisors LLC (9.98%), Citadel Advisors Holdings LP (9.98%) and 1 more | 717,198 | 9.99% | 13G (passive) | Jan 15, 2026 |
| Maier Joshua Tarlow Joint filing with 3i, LP (9.90%), 3i Management LLC (9.90%) | 369,000 | 9.90% | 13G (passive) | Feb 5, 2025 |
| Plambeck Jeremy Myung Jae | 13,339 | 100.00% | 13G (passive) | Aug 25, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BCTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cable Car Capital, LP | 216,821 | – | $702.50K | – | 0.02% |
| Sabby Management, LLC | 80,721 | – | $261.54K | +6,806 | 0.24% |
| Iridian Asset Management LLC/Ct | 65,000 | – | $210.60K | – | 0.07% |
| UBS Group AG | 43,642 | – | $141.40K | +32,101 | 0.00% |
| Hrt Financial LP | 34,904 | – | $113.00K | New | 0.00% |
| Jane Street Group, LLC | 26,515 | – | $85.91K | New | 0.00% |
| LuminArx Capital Management LP | 15,000 | – | $48.60K | – | 0.02% |
| National Bank Of Canada /Fi/ | 1,803 | – | $5.80K | +1,001 | 0.00% |
| Morgan Stanley | 1,033 | – | $3.35K | −1,988 | 0.00% |
| Federation des caisses Desjardins du Quebec | 450 | – | $1.44K | −5 | 0.00% |
| Royal Bank of Canada | 289 | – | $1.00K | +189 | 0.00% |
| Allworth Financial LP | 100 | – | $324 | – | 0.00% |
| Ssa Swiss Advisors AG | 37 | – | $121 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 34 | – | $110 | +27 | 0.00% |
| TD Waterhouse Canada Inc. | 19 | – | $66 | – | 0.00% |
| Group One Trading, L.P. | 16 | – | $52 | – | 0.00% |
| HHM Wealth Advisors, LLC | 6 | – | $20 | – | 0.00% |
| Wells Fargo & Company/Mn | 1 | – | $3 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 18 | 0M | 3 / 5 | 2 / 1 | 0M | 0M |
| Q1 2026 | 16 | 0M | 6 / 1 | 3 / 3 | 0M | 0M |
| Q4 2025 | 13 | 0M | 3 / 4 | 0 / 3 | 0M | 0M |
| Q3 2025 | 13 | 0M | 13 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BCTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 3,231 | – | $11.76K | 0.00% | May 31, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Marc Lustig Director, 10% owner | May 14, 2024 | Buy | +902,935 | $2.22 | $2.00M | 2,542,935 |
| Jamieson Bondarenko Chairman, Director | Dec 28, 2022 | Buy | +28,000 | $4.58 | $128.24K | 169,856 |
| Jamieson Bondarenko Director | Dec 20, 2022 | Buy | +22,000 | $5.35 | $117.70K | 141,856 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BriaCell Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 66,316 shares on Aug 25, 2026 over the last 90 days.
See a number that looks wrong?